GLUCAGEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glucagen, and when can generic versions of Glucagen launch?
Glucagen is a drug marketed by Novo Nordisk and is included in one NDA.
The generic ingredient in GLUCAGEN is glucagon hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLUCAGEN?
- What are the global sales for GLUCAGEN?
- What is Average Wholesale Price for GLUCAGEN?
Summary for GLUCAGEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 15 |
| Clinical Trials: | 30 |
| Patent Applications: | 134 |
| Drug Prices: | Drug price information for GLUCAGEN |
| What excipients (inactive ingredients) are in GLUCAGEN? | GLUCAGEN excipients list |
| DailyMed Link: | GLUCAGEN at DailyMed |
Recent Clinical Trials for GLUCAGEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Columbia University | Phase 1 |
| Albert Einstein College of Medicine | Phase 1 |
| Inreda Diabetic B.V. | Phase 2 |
US Patents and Regulatory Information for GLUCAGEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk | GLUCAGEN | glucagon hydrochloride | POWDER;INTRAMUSCULAR, INTRAVENOUS | 020918-001 | Jun 22, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novo Nordisk | GLUCAGEN | glucagon hydrochloride | POWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS | 020918-002 | Jun 22, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
